Mankind Pharma shares jump 3.39% amid high volume trading; stock among top gainers on Nifty Midcap 150

Shares of Mankind Pharma were trading with a gain of 3.39% at Rs 2,665.80 in Monday afternoon's session, experiencing a surge in trading volume. The stock is among the top gainers on the Nifty Midcap 150.

The company's annual consolidated revenue has shown consistent growth, increasing from Rs 6,214.43 Crore in 2021 to Rs 12,207.44 Crore in 2025. Net profit also increased from Rs 1,281.36 Crore in 2021 to Rs 1,998.88 Crore in 2025.

Here's a summary of Mankind Pharma's key annual consolidated financial data:

Heading2021202220232024

2025RevenueRs 6,214.43 CroreRs 7,781.56 CroreRs 8,749.43 CroreRs 10,334.77 Crore

Rs 12,207.44 CroreNet ProfitRs 1,281.36 CroreRs 1,438.51 CroreRs 1,297.25 CroreRs 1,926.56 Crore

Rs 1,998.88 CroreEPS31.5935.7832.0047.75

49.28BVPS121.39157.68190.30239.04

347.37ROE26.7923.2817.2420.43

13.89Debt to Equity0.050.140.020.02

0.59

The company's quarterly consolidated revenue has also shown growth. The revenue for the quarter-ending March 2025 was reported at Rs 3,079.37 Crore, compared to Rs 2,441.10 Crore in March 2024. The net profit for the quarter-ending March 2025 was Rs 422.33 Crore, compared to Rs 474.18 Crore in March 2024.

Here's a summary of Mankind Pharma's key quarterly consolidated financial data:

HeadingMar 2024Jun 2024Sep 2024Dec 2024

Mar 2025RevenueRs 2,441.10 CroreRs 2,893.42 CroreRs 3,076.51 CroreRs 3,230.00 Crore

Rs 3,079.37 CroreNet ProfitRs 474.18 CroreRs 539.16 CroreRs 656.31 CroreRs 381.08 Crore

Rs 422.33 CroreEPS11.7613.3916.319.45

10.20

Mankind Pharma has announced its 34th Annual General Meeting, as per recent corporate announcements.Mankind Pharma shares jump 3.39% amid high volume trading; stock among top gainers on Nifty Midcap 150